STAAR Low-Grade Serous Ovarian Cancer

Listen to STAAR Chair Nicole Andrews and Verastem Oncology President and CEO Dan Paterson discuss the development of a targeted treatment for LGSOC and increasing researchers’ understanding about the rare ovarian cancer. #cancerresearch #letstalkaboutLGSOC https://lnkd.in/gTbf7bAT

Congratulations to STAAR Chair Nicole Andrews for being honored with a World Ovarian Cancer Coalition award! "When we began Voices of LGSOC and Step Up America for Ovarian Cancer, STAAR had a simple but powerful vision: To give every woman a stronger and clearer voice and to ignite awareness across all communities," Nicole says. "I’m grateful for the partnerships built. This award is not only a recognition of ingenuity and dedication, but it’s a testament to the incredible strength found in collaboration and shared purpose. Together we're amplifying awareness, igniting hope, and most importantly, creating lasting change." https://lnkd.in/gAp4eWGX #lgsoc #ovariancancerawareness

Wondering what to give your loved one who has everything—including low-grade serous ovarian cancer? How about a donation that will go directly to research that could give them more time? STAAR is entirely run by volunteers and committed to improving outcomes for this highly recurrent and persistent disease. When you donate at staaroc.co/give, we’ll send you a certificate to give to your loved one with LGSOC. #CyberMonday #GivingTuesday

Join us at the first STAAR Low-Grade Serous Ovarian Cancer Patient Conference in Houston this February. Learn more about our mission — and opportunities for sponsorships — at https://lnkd.in/gguD9-Sb. #lgsoc #ovariancancer #raredisease #cancerresearch

STAAR is a community where no one with low-grade serous ovarian cancer has to face this disease alone. Read the story of how we got here on our latest STAAR blog. #cancerresearch #ovariancancer #raredisease #lgsoc

Most of the patients on the most recent clinical saw some tumor reduction. This is an incredible advancement toward an FDA-approved treatment for LGSOC. https://lnkd.in/gNFq5uzb #LGSOC #ovariancancer #cancerresearch

Calling all researchers! STAAR Ovarian Cancer Foundation is thrilled to announce up to $150,000 in research funding for projects focused on low-grade serous ovarian cancer (LGSOC). https://lnkd.in/ggVuXY_z #cancerresearch #LGSOC #ovariancancer

The first global survey of LGSOC patients been written up in the American Journal of Managed Care.

STAAR was founded four years ago by three women with low-grade serous ovarian cancer. For us, the fight is personal.

One thing we know for sure, LGSOC cells are different than high-grade serous ovarian cancer cells. STAAR is extremely grateful to researchers like Drs. Gershenson and Wong, and proud to help fund their research, recently published in Academia Oncology. #LGSOCAwarenessDay #OvarianCancerAwarenessMonth #cancerresearch